Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Neutral
Analyst Rating
Neutral
Simple Moving Average
Strong Sell
Exponential Moving Average
Strong Sell
Relative Strength Index
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
CNS Pharmaceuticals, Inc. Common Stock (CNSP)
Pharmaceutical Preparations
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
2100 WEST LOOP SOUTH, SUITE 900
HOUSTON, TX
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
11/08/2019
Market Cap
381,480
Shares Outstanding
6,220,000
Weighted SO
6,214,598
Total Employees
N/A
Upcoming Earnings
N/A
Beta
1.0790
Last Div
0.0000
Range
0.125-137.5
Chg
-0.0080
Avg Vol
4870362
Mkt Cap
381480
Exch
NASDAQ
Country
US
Phone
800 946 9185
DCF Diff
-2.1603
DCF
3.2903
Div Yield
0.0000
P/S
59.9623
EV Multiple
0.0618
P/FV
-0.0117
Div Yield %
0.0000
P/E
-0.0031
PEG
0.0000
Payout
0.0000
Current Ratio
0.3172
Quick Ratio
0.3172
Cash Ratio
0.2206
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.5803
Op Margin
-2512.7625
Pretax Margin
-2510.7743
Net Margin
-2510.7743
Eff Tax Rate
-0.0008
ROA
-6.4689
ROE
4.2891
ROCE
3.7233
NI/EBT
1.0000
EBT/EBIT
0.9992
EBIT/Rev
-2512.7625
Debt Ratio
0.0499
D/E
-0.0287
LT Debt/Cap
0.0000
Total Debt/Cap
-0.0296
Int Coverage
-2323.2372
CF/Debt
-101.4823
Equity Multi
-0.5751
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
1.7906
Asset Turnover
0.0026
OCF/Share
-33.2078
FCF/Share
-33.2182
Cash/Share
3.9601
OCF/Sales
-1965.9692
FCF/OCF
1.0003
CF Coverage
-101.4823
ST Coverage
-101.4823
CapEx Coverage
-3206.2281
Div&CapEx Cov
-3206.2281
P/BV
-0.0117
P/B
-0.0117
P/S
59.9623
P/E
-0.0031
P/FCF
-0.0305
P/OCF
-0.0040
P/CF
-0.0040
PEG
0.0000
P/S
59.9623
EV Multiple
0.0618
P/FV
-0.0117
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 6.36K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.38K | ▼ 953.00 | ▼ 818.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -2.38K | ▲ 5.41K | ▼ -818.00 |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.85 | ▼ 0.00 |
Research And Development Expenses | 0.00 | ▲ 1.48M | ▲ 1.91M | ▼ 1.90M | ▲ 3.35M | ▲ 4.27M | ▼ 2.43M |
General And Administrative Expenses | 208.58K | ▲ 1.04M | ▲ 1.09M | ▼ 896.33K | ▲ 2.15M | ▼ 1.11M | ▲ 1.11M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -953.00 | ▲ -818.00 |
Selling General And Administrative Expenses | 208.58K | ▲ 1.04M | ▲ 1.09M | ▼ 896.33K | ▲ 2.15M | ▼ 1.11M | ▲ 1.11M |
Other Expenses | -6.41M | ▲ 9.17K | ▼ 0.00 | 0.00 | ▲ 4.68M | ▼ 0.00 | 0.00 |
Operating Expenses | 208.58K | ▲ 2.52M | ▲ 3.00M | ▼ 2.79M | ▲ 5.50M | ▼ 5.38M | ▼ 3.54M |
Cost And Expenses | 208.58K | ▲ 2.52M | ▲ 3.00M | ▼ 2.79M | ▲ 5.50M | ▼ 5.38M | ▼ 3.54M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.00 | ▲ 7.00K | ▼ 6.73K |
Interest Expense | 13.97K | ▼ 3.62K | ▼ 3.26K | ▼ 2.24K | ▲ 2.31K | ▲ 2.88K | ▲ 6.63K |
Depreciation And Amortization | -6.41M | ▲ 1.09K | ▲ 3.14K | ▲ 3.49K | ▼ 2.38K | ▼ 953.00 | ▼ 818.00 |
Ebitda | -6.62M | ▲ -2.52M | ▼ -3.00M | ▲ -2.79M | ▼ -5.50M | ▲ -5.38M | ▲ -3.54M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 |
Operating Income | -208.58K | ▼ -2.52M | ▼ -3.00M | ▲ -2.79M | ▼ -5.50M | ▲ -5.38M | ▲ -3.54M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -845.55 | ▲ 0.00 |
Total Other Income Expenses Net | -6.41M | ▲ -3.62K | ▲ -3.26K | ▲ -2.24K | ▼ -2.31K | ▲ 4.12K | ▼ 102.00 |
Income Before Tax | -6.63M | ▲ -2.53M | ▼ -3.00M | ▲ -2.80M | ▼ -5.50M | ▲ -5.38M | ▲ -3.54M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 |
Income Tax Expense | 13.97K | ▼ -1.09K | ▲ 0.00 | ▲ 2.24K | ▲ 2.31K | ▼ -3.00 | ▲ 2.00 |
Net Income | -6.63M | ▲ -2.53M | ▼ -3.00M | ▲ -2.80M | ▼ -5.51M | ▲ -5.38M | ▲ -3.54M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 |
Eps | -12.66 | ▲ -5.03 | ▼ -5.42 | ▲ -3.18 | ▼ -3.82 | ▲ -0.95 | ▲ -0.41 |
Eps Diluted | -12.66 | ▲ -5.03 | ▼ -5.42 | ▲ -3.18 | ▼ -3.82 | ▲ -0.95 | ▲ -0.41 |
Weighted Average Shs Out | 523.73K | ▼ 502.41K | ▲ 553.95K | ▲ 878.44K | ▲ 1.44M | ▲ 5.63M | ▲ 8.71M |
Weighted Average Shs Out Dil | 523.73K | ▼ 502.43K | ▲ 553.95K | ▲ 878.44K | ▲ 1.44M | ▲ 5.63M | ▲ 8.71M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 282.74K | ▲ 7.24M | ▲ 14.04M | ▼ 5.00M | ▲ 10.06M | ▼ 548.72K | ▲ 815.23K |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 282.74K | ▲ 7.24M | ▲ 14.04M | ▼ 5.00M | ▲ 10.06M | ▼ 548.72K | ▲ 815.23K |
Net Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 33.00K | ▲ 652.62K | ▲ 1.46M | ▲ 2.47M | ▲ 2.51M | ▼ 839.59K | ▼ 786.05K |
Total Current Assets | 588.13K | ▲ 7.89M | ▲ 15.50M | ▼ 7.48M | ▲ 12.56M | ▼ 1.39M | ▲ 1.60M |
Property Plant Equipment Net | 0.00 | ▲ 18.17K | ▲ 23.43K | ▼ 16.11K | ▼ 5.66K | ▼ 4.93K | ▼ 4.31K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 95.20K | ▼ 0.00 | ▲ 334.14K | ▲ 1.26M | ▼ 482.81K | ▼ 307.61K | ▼ 55.30K |
Total Non Current Assets | 95.20K | ▼ 18.17K | ▲ 357.57K | ▲ 1.28M | ▼ 488.47K | ▼ 312.54K | ▼ 59.60K |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Total Assets | 683.33K | ▲ 7.91M | ▲ 15.85M | ▼ 8.76M | ▲ 13.05M | ▼ 1.70M | ▼ 1.66M |
Account Payables | 128.87K | ▲ 289.50K | ▲ 946.33K | ▲ 1.52M | ▲ 3.68M | ▲ 5.83M | ▲ 5.88M |
Short Term Debt | 316.92K | ▼ 0.00 | ▲ 439.29K | ▼ 387.79K | ▲ 409.97K | ▼ 300.81K | ▼ 213.10K |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 23.60K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -5.88M |
Other Current Liabilities | 763.25K | ▼ 21.50K | ▲ 519.80K | ▼ 224.95K | ▲ 828.39K | ▼ 0.00 | ▲ 5.88M |
Total Current Liabilities | 1.23M | ▼ 311.00K | ▲ 1.91M | ▲ 2.14M | ▲ 4.92M | ▲ 6.13M | ▼ 6.09M |
Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 4.09M | ▼ 0.00 | 0.00 |
Total Non Current Liabilities | 445.78K | ▼ 289.50K | ▲ 1.39M | ▲ 1.91M | ▲ 4.09M | ▼ 0.00 | 0.00 |
Other Liabilities | -445.78K | ▲ -289.50K | ▼ -1.39M | ▼ -1.91M | ▼ -4.09M | ▲ 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 1.23M | ▼ 311.00K | ▲ 1.91M | ▲ 2.14M | ▲ 4.92M | ▲ 6.13M | ▼ 6.09M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 12.70K | ▲ 16.45K | ▲ 23.86K | ▲ 27.93K | ▼ 1.62K | ▲ 6.21K | ▲ 10.67K |
Retained Earnings | -7.61M | ▼ -11.49M | ▼ -20.95M | ▼ -34.98M | ▼ -50.72M | ▼ -69.57M | ▼ -73.11M |
Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 7.05M | ▲ 19.07M | ▲ 34.87M | ▲ 41.58M | ▲ 58.85M | ▲ 65.13M | ▲ 68.67M |
Total Stockholders Equity | -549.30K | ▲ 7.60M | ▲ 13.95M | ▼ 6.62M | ▲ 8.13M | ▼ -4.43M | ▲ -4.43M |
Total Equity | -549.30K | ▲ 7.60M | ▲ 13.95M | ▼ 6.62M | ▲ 8.13M | ▼ -4.43M | ▲ -4.43M |
Total Liabilities And Stockholders Equity | 683.33K | ▲ 7.91M | ▲ 15.85M | ▼ 8.76M | ▲ 13.05M | ▼ 1.70M | ▼ 1.66M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 683.33K | ▲ 7.91M | ▲ 15.85M | ▼ 8.76M | ▲ 13.05M | ▼ 1.70M | ▼ 1.66M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 316.92K | ▼ 0.00 | ▲ 439.29K | ▼ 387.79K | ▲ 409.97K | ▼ 300.81K | ▼ 213.10K |
Net Debt | 34.18K | ▼ -7.24M | ▼ -13.60M | ▲ -4.62M | ▼ -9.65M | ▲ -247.92K | ▼ -602.12K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -6.63M | ▲ -2.53M | ▼ -3.00M | ▲ -2.80M | ▼ -5.50M | ▲ -5.38M | ▲ -3.54M |
Depreciation And Amortization | 0.00 | ▲ 1.09K | ▲ 3.14K | ▲ 3.49K | ▼ 2.38K | ▼ 953.00 | ▼ 818.00 |
Deferred Income Tax | 0.00 | 0.00 | ▼ -833.78K | ▼ -835.37K | ▲ 0.00 | ▼ -234.58K | ▲ 0.00 |
Stock Based Compensation | 51.52K | ▲ 190.32K | ▲ 362.95K | ▼ 316.91K | ▼ 289.72K | ▼ 232.68K | ▼ 202.93K |
Change In Working Capital | 15.71K | ▼ -184.21K | ▲ 1.19M | ▼ -762.05K | ▲ 2.57M | ▲ 2.61M | ▼ 149.13K |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | 38.07K | ▼ -5.87K | ▲ 696.15K | ▼ 61.25K | ▲ 2.22M | ▼ 1.43M | ▼ 46.14K |
Other Working Capital | -22.37K | ▼ -178.34K | ▲ 494.31K | ▼ -823.30K | ▲ 354.02K | ▲ 2.61M | ▼ 149.13K |
Other Non Cash Items | 6.40M | ▼ 44.57K | ▲ 835.37K | 835.37K | ▼ 334.61K | ▼ 234.32K | ▼ 204.38K |
Net Cash Provided By Operating Activities | -159.49K | ▼ -2.48M | ▲ -1.45M | ▼ -3.24M | ▲ -2.31M | ▼ -2.54M | ▼ -3.19M |
Investments In Property Plant And Equipment | 0.00 | ▼ -11.74K | ▲ 0.00 | ▼ -2.08K | ▲ 1.00 | ▼ -2.16K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash Used For Investing Activities | 0.00 | ▼ -11.74K | ▲ 0.00 | ▼ -2.08K | ▲ 1.00 | ▼ -2.16K | ▲ 0.00 |
Debt Repayment | 0.00 | ▼ -35.00K | ▼ -43.08K | ▼ -82.83K | ▲ -79.17K | ▲ -70.67K | ▼ -87.70K |
Common Stock Issued | 0.00 | ▲ 8.79M | ▲ 14.22M | ▼ 9.57M | ▼ 5.41M | ▼ 2.25M | ▲ 3.55M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 6.00K | ▲ 76.53K | ▼ 0.00 | ▼ -9.57M | ▲ 118.00 | ▲ 2.18K | ▼ -75.30K |
Net Cash Used Provided By Financing Activities | 6.00K | ▲ 8.83M | ▲ 14.18M | ▼ -82.83K | ▲ 5.33M | ▼ 2.18M | ▲ 3.46M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash | -153.49K | ▲ 6.34M | ▲ 12.73M | ▼ -3.32M | ▲ 3.03M | ▼ -360.83K | ▲ 266.51K |
Cash At End Of Period | 555.13K | ▲ 7.24M | ▲ 14.04M | ▼ 5.00M | ▲ 10.06M | ▼ 548.72K | ▲ 815.23K |
Cash At Beginning Of Period | 708.63K | ▲ 899.51K | ▲ 1.31M | ▲ 8.33M | ▼ 7.03M | ▼ 909.55K | ▼ 548.72K |
Operating Cash Flow | -159.49K | ▼ -2.48M | ▲ -1.45M | ▼ -3.24M | ▲ -2.31M | ▼ -2.54M | ▼ -3.19M |
Capital Expenditure | 0.00 | ▼ -11.74K | ▲ 0.00 | ▼ -2.08K | ▲ 1.00 | ▼ -2.16K | ▲ 0.00 |
Free Cash Flow | -159.49K | ▼ -2.49M | ▲ -1.45M | ▼ -3.24M | ▲ -2.31M | ▼ -2.54M | ▼ -3.19M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)